A newly developed parallel microdevice leverages artificial intelligence to facilitate high-throughput intracellular delivery and rapid quantitative single-cell analysis. This technology aims to streamline applications ranging from drug discovery to gene modulation by overcoming challenges of scalability and efficiency in cell engineering platforms, offering profound implications for precision medicine and cellular therapeutics.